Tag: Targeted treatment for thyroid tumors

Home / Targeted treatment for thyroid tumors

Categories

Selpercatinib is approved by FDA for RET fusion-positive thyroid cancer

  May 2024: The Food and Drug Administration has officially approved selpercatinib (Retevmo, Eli Lilly and Company) for the treatment of advanced or metastatic RET fusion-positive thyroid canc...
targeted-treatment-for-thyroid-tumors

Scan the code